Search

Author/Creator Miller, David S

1. 2022-RA-653-ESGO The impact of histology, prior therapy, and dMMR status on lenvatinib + pembrolizumab outcomes in patients with advanced endometrial cancer: A subgroup analysis of Study 309/KEYNOTE-775. (20th October 2022)

Authors:
Lorusso, Domenica; Makker, Vicky; Herraez, Antonio Casado; Monk, Bradley J; Mackay, Helen; Santin, Alessandro D; Miller, David S; Moore, Richard; Baron-Hay, Sally; Ray-Coquard, Isabelle; Shapira-Frommer, Ronnie; Ushijima, Kimio; Yonemori, Kan; Kim, Yong Man; Guerra Alia, Eva M; Sanli, Ulus A; Hua...
Journal:
International journal of gynecological cancer
Issue:
Volume 32(2022)Supplement 2
Page Start:
A102
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Serial genomic analysis of endometrium supports the existence of histologically indistinct endometrial cancer precursors. Issue 1 (9th March 2021)

Authors:
Aguilar, Mitzi; Zhang, He; Zhang, Musi; Cantarell, Brandi; Sahoo, Subhransu S; Li, Hao‐Dong; Cuevas, Ileana C; Lea, Jayanthi; Miller, David S; Chen, Hao; Zheng, Wenxin; Gagan, Jeffrey; Lucas, Elena; Castrillon, Diego H
Journal:
Journal of pathology
Issue:
Volume 254:Issue 1(2021)
Page Start:
20
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗